Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
AssigneeBoard of Regents, The University of Texas System
InventorLenard Lichtenberger
Life of this patent
Estimating the term…
Abstract
A new pharmaceutical composition is disclosed comprising a purified phospholipid-selective and/for nonselective non-steroidal, anti-inflammatory drug associated complex and methods for making and using same. A screening method for identifying compounds that form phospholipid associated complexes is also disclosed.
Claims32
A method comprising the step of:
- contacting one selective or nonselective non-steroidal, anti-inflammatory drug (sns-NSAID) or a plurality of sns-NSAIDs and one phospholipid (PL) or a plurality of PLs in a polar solvent under conditions adapted to produce a solution including purified PL-sns-NSAID associated complexes;
- and
- removing the solvent below a desired level to form a composition comprising purified PL-sns-NSAID associated complexes.
A method comprising the steps of:
- administering a therapeutically effective amount of a composition to an animal including a human,
- where the composition is prepared by a method comprising the steps of:
- contacting one selective or nonselective non-steroidal, anti-inflammatory drug (sns-NSAID) or a plurality of sns-NSAIDs and one phospholipid (PL) or a plurality of PLs in a polar solvent under conditions adapted to produce a solution including PL-sns-NSAID associated complexes;
- and
- removing the solvent to a desired level to form a composition comprising purified PL-sns-NSAID associated complexes.
A composition comprising purified associated complexes of one phospholipid (PL) or a plurality of PLs and one selective or nonselective non-steroidal, anti-inflammatory drug (sns-NSAID) or a plurality of sns-NSAIDs having a weight ratio of sns-NSAIDs to PLs where the sns-NSAID is present in an amount sufficient to prevent precipitation of the PLs when the composition is dissolved in a polar solvent in which the PL has moderate, low or no solubility.
Dependencies are inferred from the claim text.